Human fibrinogen/Human thrombin (Instituto Grifols)

N/A

Report date: 2024/07/30 17:49:24

Base Information

Drug NameHuman fibrinogen/Human thrombin (Instituto Grifols)
Drug Alias NameFibrin Sealant (Human)/Human thrombin (Instituto Grifols)人纤维蛋白原/人凝血酶（Instituto Grifols）Fibrinogen (Instituto Grifols)FIB (Instituto Grifols)Fibrinogen human (Instituto Grifols) +[8] 
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionFibrinogen stimulantsFibrinogen replacements
TargetsFibrinogen
Therapy Area/IndicationsHemorrhageAfibrinogenemia
Global Approved IndicationsHemorrhage
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2017/11/01
Country/TerritoryEU
CombinationsYes Human fibrinogen (fibrinogen deficiency) (Guangdong Weilun Biological Products)Human thrombin topical (Grifols)
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGrifols Sa
China Registration ClassN/A

Develop Information

Active CompaniesGrifols SaInstituto Grifols Sa
Inactive CompaniesN/A
Active IndicationsHemorrhage
Inactive IndicationsAfibrinogenemia

Other Information

ATC CodeB02BB01
Related LinksN/A